Article
Site-Specific Integration of <i>TRAIL</i> in iPSC-Derived Mesenchymal Stem Cells for Targeted Cancer Therapy
1 Jan 2022
Abstract excerpt
Mesenchymal stem cells (MSCs) are a promising cellular vehicle for transferring anti-cancer factors to malignant tumors. Currently, a variety of anti-cancer agents, including the tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL), have been loaded into MSCs derived from a range of sources through different engineering methods. These engineered MSCs exhibit enormous therapeutic potential for...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
